CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
pembrolizumab in participants with locally advanced or metastatic melanoma of the skin. All participants will receive active drugs; no one w...
Phase 2
Nashville, Tennessee, United States and 1 other location
This is a Phase 3, randomized, multi-center, open-label study of neoadjuvant darovasertib in subjects with primary non-metastatic uveal melanoma...
Phase 3
Nashville, Tennessee, United States and 74 other locations
Neoadjuvant/adjuvant IDE196 (darovasertib) in patients with primary uveal melanoma...
Phase 2
Nashville, Tennessee, United States and 23 other locations
binimetinib, and pembrolizumab) given together for the treatment of melanoma that:* is advanced or metastatic (spread to other parts of the ...
Phase 3
Nashville, Tennessee, United States and 132 other locations
1/2, open-label study of a modified interleukin-2 fusion protein (IOV 3001) in participants with previously treated, unresectable or metastatic melanoma...
Phase 1, Phase 2
Nashville, Tennessee, United States and 1 other location
alone in participants with untreated, unresectable or metastatic melanoma. Participants randomized to the pembrolizumab monotherapy arm who ...
Phase 3
Nashville, Tennessee, United States and 71 other locations
cell death protein-1 (PD-1) inhibitor, in patients with metastatic melanomas or advanced solid tumors. Our hypothesis is that restoration of...
Phase 1, Phase 2
Nashville, Tennessee, United States and 20 other locations
and overall survival (OS) for patients with NRAS-mutant (NRASm) melanoma who are randomized to receive the combination of naporafenib + tram...
Phase 3
Nashville, Tennessee, United States and 58 other locations
The study is focused on patients with a type of skin cancer known as melanoma. The aim of the study is to see how safe and effective the com...
Phase 3
Nashville, Tennessee, United States and 100 other locations
efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indeterminate lesions (IL) or small choroidal melanoma...
Phase 3
Nashville, Tennessee, United States and 64 other locations
Clinical trials
Research sites
Resources
Legal